Ro J - Search Results

1

Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients.

Lee S, Kim EY, Kang SH, Kim SW, Kim SK, Kang KW, Kwon Y, Shin KH, Kang HS, Ro J, Lee ES. Lee S, et al. Among authors: ro j. Breast Cancer Res Treat. 2007 May;102(3):283-8. doi: 10.1007/s10549-006-9330-9. Epub 2006 Oct 25. Breast Cancer Res Treat. 2007. PMID: 17063280 Clinical Trial.

2

Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer.

Jung SY, Kim HY, Nam BH, Min SY, Lee SJ, Park C, Kwon Y, Kim EA, Ko KL, Shin KH, Lee KS, Park IH, Lee S, Kim SW, Kang HS, Ro J. Jung SY, et al. Among authors: ro j. Breast Cancer Res Treat. 2010 Apr;120(3):627-37. doi: 10.1007/s10549-010-0780-8. Epub 2010 Feb 9. Breast Cancer Res Treat. 2010. PMID: 20143153

3

Locoregional recurrence of breast cancer in patients treated with breast conservation surgery and radiotherapy following neoadjuvant chemotherapy.

Min SY, Lee SJ, Shin KH, Park IH, Jung SY, Lee KS, Ro J, Lee S, Kim SW, Kim TH, Kang HS, Cho KH. Min SY, et al. Among authors: ro j. Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e697-705. doi: 10.1016/j.ijrobp.2010.10.014. Epub 2010 Dec 2. Int J Radiat Oncol Biol Phys. 2011. PMID: 21129858

4

Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients.

Kwon Y, Ro J, Kang HS, Kim SK, Hong EK, Khang SK, Gong G, Ro JY. Kwon Y, et al. Among authors: ro j, ro jy. Oncol Rep. 2011 Apr;25(4):1063-71. doi: 10.3892/or.2011.1157. Epub 2011 Jan 21. Oncol Rep. 2011. PMID: 21258771

5

Accumulation of p53 determined by immunohistochemistry as a prognostic marker in node negative breast cancer; analysis according to St Gallen consensus and intrinsic subtypes.

Jung SY, Jeong J, Shin SH, Kwon Y, Kim EA, Ko KL, Shin KH, Ro J, Lee KS, Park IH, Lee S, Kim SW, Kang HS. Jung SY, et al. Among authors: ro j. J Surg Oncol. 2011 Mar 1;103(3):207-11. doi: 10.1002/jso.21819. Epub 2010 Dec 22. J Surg Oncol. 2011. PMID: 21337548

6

Phase II trial of preoperative paclitaxel, gemcitabine, and trastuzumab combination therapy in HER2 positive stage II/III breast cancer: the Korean Cancer Study Group BR 07-01.

Im SA, Lee KS, Ro J, Lee ES, Kwon Y, Ahn JH, Ahn JS, Kim JH, Kang HS, Shin KH, Noh DY, Park IA, Kim SB, Im YH, Ha SW. Im SA, et al. Among authors: ro j. Breast Cancer Res Treat. 2012 Apr;132(2):589-600. doi: 10.1007/s10549-011-1852-0. Epub 2011 Nov 18. Breast Cancer Res Treat. 2012. PMID: 22094934 Clinical Trial.

7

Locoregional recurrence of breast conserving surgery after preoperative chemotherapy in korean women with locally advanced breast cancer.

Lee S, Kim SW, Kim SK, Lee KS, Kim EA, Kwon Y, Shin KH, Kang HS, Ro J, Lee ES. Lee S, et al. Among authors: ro j. J Breast Cancer. 2011 Dec;14(4):289-95. doi: 10.4048/jbc.2011.14.4.289. Epub 2011 Dec 27. J Breast Cancer. 2011. PMID: 22323915 Free PMC article.

8

Stage-to-stage comparison of neoadjuvant chemotherapy versus adjuvant chemotherapy in pathological lymph node positive breast cancer patients.

Lee NK, Shin KH, Park IH, Lee KS, Ro J, Jung SY, Lee S, Kim SW, Kim TH, Kim JY, Kang HS, Cho KH. Lee NK, et al. Among authors: ro j. Jpn J Clin Oncol. 2012 Nov;42(11):995-1001. doi: 10.1093/jjco/hys130. Epub 2012 Aug 21. Jpn J Clin Oncol. 2012. PMID: 22911001

9

Comparison of sentinel lymph node biopsy guided by the multimodal method of indocyanine green fluorescence, radioisotope, and blue dye versus the radioisotope method in breast cancer: a randomized controlled trial.

Jung SY, Kim SK, Kim SW, Kwon Y, Lee ES, Kang HS, Ko KL, Shin KH, Lee KS, Park IH, Ro J, Jeong HJ, Joo J, Kang SH, Lee S. Jung SY, et al. Among authors: ro j. Ann Surg Oncol. 2014 Apr;21(4):1254-9. doi: 10.1245/s10434-013-3437-0. Epub 2013 Dec 20. Ann Surg Oncol. 2014. PMID: 24356798 Clinical Trial.

10

Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II/III breast cancer patients.

Jung SY, Shin KH, Kim M, Chung SH, Lee S, Kang HS, Lee ES, Kwon Y, Lee KS, Park IH, Ro J. Jung SY, et al. Among authors: ro j. Breast Cancer Res Treat. 2014 Nov;148(1):91-8. doi: 10.1007/s10549-014-3137-x. Epub 2014 Sep 25. Breast Cancer Res Treat. 2014. PMID: 25253173

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,140 results

Search Page

Filters